2014Gansu Medical JournalRequires access

Clinical effects and security analysis of combination of carvedilol and valsartan on patients with chronic heart failure

Bai Wen-lia

Open publisher page 0 citations

Abstract

Objective: To explore clinical effects and security analysis of combination of carvedilol and valsartan on patients with chronic heart failure. Methods: 118 patients with chronic heart failure patients in our hospital were divided randomly into observation group and control group according to the figure.The control group were taken valsartan and the observation group were taken carvedilol treatment on the basis of taking valsartan in which the clinical effect and security were compared in two groups. Results: The left ventricular end-systolic diameter,left ventricular end-diastolic diameter,left ventricular end-systolic capacity,left ventricular end-diastolic volume, left ventricular ejection fraction and stroke volume were better improved in the observation group than that in the control group in which the difference was statistically significant(P0.05). The total efficiency in observation group was 94.92%,the control group was 83.05% in which the difference was statistically significant(P0.05). There was no serious adverse drug reactions in the observation group and control group. Conclusion:Combination of carvedilol and valsartan on patients with chronic heart failure is a safe and reliable treatment.

About this research paper

What this paper is about

Objective: To explore clinical effects and security analysis of combination of carvedilol and valsartan on patients with chronic heart failure. Methods: 118 patients with chronic heart failure patients in our hospital were divided randomly into observation group and control group according to the figure.The control group were taken valsartan and the observation group were taken carvedilol treatment on the basis of taking valsartan in which the clinical effect and security were compared in two groups. Results: The left ventricular end-systolic diameter,left ventricular end-diastolic diameter,left ventricular end-systolic capacity,left ventricular end-diastolic volume, left ventricular ejection fraction and stroke volume were better improved in the observation group than that in the control group in which the difference was statistically significant(P0.05). The total efficiency in observation group was 94.92%,the control group was 83.05% in which the difference was statistically significant(P0.05). There was no serious adverse drug reactions in the observation group and control group. Conclusion:Combination of carvedilol and valsartan on patients with chronic heart failure is a safe and reliable treatment.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To explore clinical effects and security analysis of combination of carvedilol and valsartan on patients with chronic heart failure. Methods: 118 patients with chronic heart failure patients in our hospital were divided randomly into observation group and control group according to the figure.The control group were taken valsartan and the observation group were taken carvedilol treatment on the basis of taking valsartan in which the clinical effect and security were compared in two groups. Results: The left ventricular end-systolic diameter,left ventricular end-diastolic diameter,left ventricular end-systolic capacity,left ventricular end-diastolic volume, left ventricular ejection fraction and stroke volume were better improved in the observation group than that in the control group in which the difference was statistically significant(P0.05). The total efficiency in observation group was 94.92%,the control group was 83.05% in which the difference was statistically significant(P0.05). There was no serious adverse drug reactions in the observation group and control group. Conclusion:Combination of carvedilol and valsartan on patients with chronic heart failure is a safe and reliable treatment.

Key concepts: Valsartan, Medicine, Carvedilol, Ejection fraction, Cardiology, Heart failure, Internal medicine, Stroke volume

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical effects and security analysis of combination of carvedilol and valsartan on patients with chronic heart failure — Research Paper | ScholarLens